ArticleRadiology case reports2026
Fetal cardiac rhabdomyoma: Two prenatally diagnosed cases with contrasting outcomes.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal cardiac rhabdomyoma is the most frequent primary cardiac tumor diagnosed in utero and carries a strong association with tuberous sclerosis complex. We present 2 prenatally diagnosed cases with contrasting postnatal outcomes. In the first case, a 28-year-old primigravida was diagnosed at 32 weeks with multiple intracardiac echogenic masses; the largest, a 22 mm polylobulated left ventricular lesion prolapsing through the mitral valve, caused hemodynamically significant obstruction requiring surgical resection at 15 days of life. In the second case, a 25-year-old primigravida with multiple masses detected at 22 weeks was followed conservatively; postnatal echocardiography demonstrated spontaneous regression with a favorable outcome. In both cases, initial neurological, imaging, dermatological, and genetic evaluations did not reveal evidence of tuberous sclerosis complex at the time of assessment. These cases illustrate the variable clinical course of fetal cardiac rhabdomyoma and underscore the importance of risk-stratified echocardiographic monitoring, individualized multidisciplinary management, and long-term surveillance for tuberous sclerosis complex regardless of initial evaluation results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.